Showing results (31-40 of 57) with videos related to
Sort By:
Pageof 6
Nature Biotechnology|December 24, 2002
Fingerprinting the circulating repertoire of antibodies from cancer patientsPaul J Mintz, Jeri Kim, Kim-Anh Do, et al.Cancer|April 23, 2014
A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701)Gerold Bepler, Ralph G Zinner, James Moon, et al.Oncogene|October 10, 2020
S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancerHua Shen, Gao-Chan Wang, Xiang Li, et al.Clinical Lung Cancer|April 28, 2006
Asian ethnicity as a predictor of response in patients with non-small-cell lung cancer treated with gefitinib on an expanded access programSheeba K Thomas, Frank V Fossella, Diane Liu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2009
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426Alex A Adjei, Sumithra J Mandrekar, Grace K Dy, et al.Clinical Lung Cancer|May 7, 2021
Description of a Lung Cancer Hotspot: Disparities in Lung Cancer Histology, Incidence, and Survival in Kentucky and Appalachian KentuckyChristine F Brainson, Bin Huang, Quan Chen, et al.Molecular Cancer Therapeutics|September 26, 2014
Triple-negative breast cancer patients treated at MD Anderson Cancer Center in phase I trials: improved outcomes with combination chemotherapy and targeted agentsPrasanth Ganesan, Stacy Moulder, J Jack Lee, et al.Oncotarget|March 3, 2016
Advanced malignancies treated with a combination of the VEGF inhibitor bevacizumab, anti-EGFR antibody cetuximab, and the mTOR inhibitor temsirolimusXiaochun Liu, Susan Kambrick, Siqing Fu, et al.Molecular Cancer Therapeutics|March 12, 2009
Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cellsRalph G Zinner, Brittany L Barrett, Elmira Popova, et al.Cancer|July 15, 2016
Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trialsGoldy C George, Eucharia C Iwuanyanwu, Karen O Anderson, et al.Pageof 6